Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

136.11
Delayed Data
As of 4:00pm ET
 +0.71 / +0.52%
Today’s Change
95.80
Today|||52-Week Range
160.00
+24.84%
Year-to-Date
Jazz Pharma (JAZZ) Q4 Earnings: Is a Surprise in Store?
Feb 23 / Zacks.com - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Feb 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close135.40
Today’s open134.96
Day’s range133.29 - 136.18
Volume331,055
Average volume (3 months)636,756
Market cap$8.1B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+462.37%
Earnings growth (this year)+5.18%
Earnings growth (next 5 years)+16.30%
Revenue growth (last year)+12.95%
P/E ratio23.8
Price/Sales6.69
Price/Book5.19

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.41+0.78%
RDYDr.Reddy's Laborator...-0.20-0.46%
SGENSeattle Genetics Inc-0.34-0.54%
UTHRUnited Therapeutics ...-0.73-0.50%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$2.64
Annual revenue (last year)$1.3B
Annual profit (last year)$329.5M
Net profit margin24.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs